LAPORTE EURO
keyboard_backspaceBack to Home
Contact
1 allée baco
44000 Nantes
France
Président
About us
LAPORTE EURO is the European subsidiary of LAPORTE & ASSOCIES, a Canadian company with over 450 employees, specialized in engineering for the pharmaceutical, agri-food and bioindustrial industries.
The company has several offices in France (Nantes, Paris, Lyon and Pau), Switzerland (Geneva and Vevey) and Belgium (south of Brussels).
Business offer
LAPORTE EURO supports its customers in the design of laboratories and production plants.
Our team stands out for its “Process” approach which places our customers' needs at the heart of the design process.
LAPORTE EURO offers a range of services:
- Strategic consulting: Master plan, process studies, regulatory compliance;
- Engineering studies: Feasibility, preliminary studies, detailed design;
- Construction engineering / project execution: Site supervision and coordination, installation, commissioning;
- Qualification / validation: Master validation plan, risk analysis, QC/IQ/OQ/QP.
To provide these services, a multidisciplinary team offers its expertise in the following fields: Process, Utilities, Air treatment, Electricity, Clean rooms, Comissioning / Qualification / Validation, Automation and industrial IT, CQV.
Activities
- Service
- Pre-industrial demonstrator
- Bioproduction
- Batches production type
- Mammalian
- Insect
- Yeast
- Bacterial
- GLP compliance
- GMP compliance
- Pilot Batches
- Tests
- Optimization
- Scale-Up process
- Process optimization & validation
- Volume
- Preclinical / Tox
- Low volume (< 200 L)
- High volume (200 – 2000 L)
- Very high volume (> 2000 L)
- Commercial
- USP (Scale-Up)
- Cell expansion
- Inoculation
- Low volume containers to Bioreactors
- DSP (Recovery)
- Harvest
- Filtration
- Purification
- Fill & Finish
- Aseptic filling
- Lyophilization
- Batch release
- Storage matter
- Instruction
- Logistic
- Cell cryopreservation
- Controlled-rated freezer
- thaw
- CMC/analytical quality assessment, quality control
- Cross contamination
- Sterility
- Bioproduction engineering
- Cell Expansion
- Stirred tank Bioreactor
- Wave bioreactor
- Cell factory
- Microcarrier-based culture
- Organoids culture
- Capsules culture
- Scale-Up
- Process optimization
- Automated manufacturing
- On-line monitoring
- Automated high throughput microbioreactor system
- Non-GMP expansion
- GMP expansion
- Other
- Purification/Extraction
- Filtration / microfiltration / ultrafiltration
- Centrifugation
- Chromatography
- CGMP
- Bioproduction modeling
- Metabolic / Kinetic modeling
- Control / command
- Global optimization
- Economic analyses
- Artificial Intelligence tools
- Formulation
- Conditioning
- Storage
- Delivery
- Transport
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Bioproduction/CMC/Analytical Quality Assessment, Quality Control
- Bioproduction
- Scale-Up
- Automated manufacturing
- Automated high throughput microbioreactor system
- Supply chain logistics
- Tracking process
- Monitoring logistics
- Non-GMP pilot batch
- GMP batch
- Cleaning
- CGMP
- Cross contamination
- Sterility
- Deviations
- Quality control
- Contaminants detection
- Safety for gene-edited cells
- Translocation
- anti-nuclease response
- cytokine-independent growth
- CMC
- GLP compliance
- for preclinical NCS (non-clinical safety) studies
- viral safety testing
- GMP compliance
- Formulation
- Formulation
- Lyophilization
- Bioproduction GMP
- Vaccine platform type
- Recombinant protein expression
- Synthetic Peptides or oligomers
- Virus-like particles (VLP) and nanoparticle-based carriers
- killed/inactivated virus
- Live attenuated virus
- Viral vector encoding target antigen
- DNA plasmid vaccine
- mRNA vaccine
- Lipid delivery vehicle
- Outer-membrane vesicles (OMV)
- Polysaccharides/ conjugated vaccines
- Other
- Pilot Batches scale
- Process development & optimization
- Scale-Up & Validation
- Comparability characterization protocol
- Manufacturing Volume
- Small volume (< 100 L) adjusted to phase I/II needs: specify volume
- Large volume (100 – 1000 L) adapted for phase III needs
- Final scale up volume (> 1000 L) and validation for manufacturing
- Commercial supply during life cycle management
- USP (Scale-Up)
- DSP (Recovery)
- Fill & finish
- Lyophilization
- Prefilled syringe
